World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 104 604 558 53 49 337 58961
Medicine 104 6910 6499 665 635 343 59055

Ravinder N. Maini publications per year

The chart shows the history of publications by Ravinder N. Maini between 1974 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Ravinder N. Maini published across 52 years, from 1974 to 2025, averaging 6.7 papers a year. Output peaked at 29 publications in 1997. 3 of the 350 publications appeared in the last two years.

No. of publications
5 10 15 20 25
Bar chart. Horizontal axis: year, 1974 to 2025. Vertical axis: number of publications, 0 to 29. Peak 29 publications in 1997. 1974: 1 publication 1975: 0 publications 1976: 2 publications 1977: 0 publications 1978: 0 publications 1979: 2 publications 1980: 2 publications 1981: 5 publications 1982: 2 publications 1983: 7 publications 1984: 5 publications 1985: 12 publications 1986: 9 publications 1987: 7 publications 1988: 18 publications 1989: 19 publications 1990: 7 publications 1991: 11 publications 1992: 13 publications 1993: 14 publications 1994: 17 publications 1995: 19 publications 1996: 10 publications 1997: 29 publications 1998: 17 publications 1999: 15 publications 2000: 19 publications 2001: 14 publications 2002: 13 publications 2003: 7 publications 2004: 13 publications 2005: 7 publications 2006: 7 publications 2007: 1 publication 2008: 12 publications 2009: 1 publication 2010: 4 publications 2011: 0 publications 2012: 1 publication 2013: 0 publications 2014: 0 publications 2015: 2 publications 2016: 0 publications 2017: 0 publications 2018: 0 publications 2019: 0 publications 2020: 2 publications 2021: 0 publications 2022: 0 publications 2023: 1 publication 2024: 1 publication 2025: 2 publications
1974 2025

350 publications in total across all disciplines

View publications per year as a table
Ravinder N. Maini: publications per year, 1974 to 2025
Year Publications
1974 1
1975 0
1976 2
1977 0
1978 0
1979 2
1980 2
1981 5
1982 2
1983 7
1984 5
1985 12
1986 9
1987 7
1988 18
1989 19
1990 7
1991 11
1992 13
1993 14
1994 17
1995 19
1996 10
1997 29
1998 17
1999 15
2000 19
2001 14
2002 13
2003 7
2004 13
2005 7
2006 7
2007 1
2008 12
2009 1
2010 4
2011 0
2012 1
2013 0
2014 0
2015 2
2016 0
2017 0
2018 0
2019 0
2020 2
2021 0
2022 0
2023 1
2024 1
2025 2
Total 350
Download as CSV

Ravinder N. Maini publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Ravinder N. Maini sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 332–341 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 337 publications — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99 337
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Ravinder N. Maini D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Ravinder N. Maini sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 104–105 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 104 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54 104
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Research.com Recognitions

  • 2010 - Member of the National Academy of Sciences
  • 2007 - Fellow of the Royal Society, United Kingdom

Overview

Ravinder N. Maini is affiliated with Imperial College London in the United Kingdom and conducts research primarily in the field of Medicine. Their work spans several subfields including Infectious Diseases, Information Systems, Neurology, Rheumatology, and Immunology. The research topics covered by Maini include COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Long-Term Effects of COVID-19, Rheumatoid Arthritis Research and Therapies, Biosimilars and Bioanalytical Methods, Monoclonal and Polyclonal Antibodies Research, and Blood groups and transfusion.

Maini has contributed to multiple recent publications across various scientific venues. These include:

  • "Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed," 2020, The Lancet
  • "25 years of biologic DMARDs in rheumatology," 2023, Nature Reviews Rheumatology
  • "Prevalence and risk factors of alloimmunization in multi-transfused pediatric patients: A cross-sectional study from a sub-Himalayan tertiary care hospital in Uttarakhand India," 2024, Transfusion Clinique et Biologique
  • "Kölliker's Organ Functions as a Developmental Hub in Mouse Cochlea Regulating Spiral Limbus and Tectorial Membrane Development," 2025, Journal of Neuroscience
  • "Digital Banking Fraud in India: Typologies, Victim Behaviour, and AI-Enabled Risk Governance in a Global Context," 2025, International Journal For Multidisciplinary Research

Their research collaborations involve frequent coauthors including:

  • Marc Feldmann
  • James N. Woody
  • Stephen T. Holgate
  • Gregory Winter
  • Matthew Rowland

Maini's works have appeared in a range of journals reflecting a multidisciplinary approach. Primary publication venues include:

  • The Lancet
  • Nature Reviews Rheumatology
  • Transfusion Clinique et Biologique
  • Journal of Neuroscience
  • International Journal For Multidisciplinary Research

Their research contributions cover notable medical themes, including investigations into the immune response mediated by biologic disease-modifying antirheumatic drugs (DMARDs), clinical aspects of COVID-19 therapeutics, blood transfusion-related immunology, and applications of artificial intelligence governance in digital banking fraud contexts.

Maini's recognition includes election as a Fellow of the Royal Society in the United Kingdom in 2007 and membership in the National Academy of Sciences since 2010.

Best Publications

  • Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

    P E Lipsky;D M van der Heijde;E W St Clair;D E Furst

  • Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.

    R Maini;E W St Clair;F Breedveld;D Furst

  • ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS

    Marc Feldmann;Fionula M. Brennan;Ravinder N. Maini

  • Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.

    M J Elliott;R N Maini;M Feldmann;J R Kalden

  • Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.

    Ravinder N. Maini;Ferdinand C. Breedveld;Joachim R. Kalden;Josef S. Smolen

  • Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community.

    Claudio Vitali;Stefano Bombardieri;Haralampos M. Moutsopoulos;Genesio Balestrieri

  • Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

    Marc Feldmann;Ravinder N. Maini

  • Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial

    E William St Clair;Désirée M F M van der Heijde;Josef S Smolen;Ravinder N Maini

  • Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha

    M J Elliott;R N Maini;M Feldmann;A Long-Fox

  • Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.

    Richard O. Williams;Marc Feldmann;Ravinder N. Maini

  • Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis.

    F M Brennan;D Chantry;A Jackson;R Maini

  • Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate.

    R N Maini;P C Taylor;J Szechinski;K Pavelka

  • Mesenchymal precursor cells in the blood of normal individuals

    Nathan J Zvaifler;Lilla Marinova-Mutafchieva;Gill Adams;Christopher J Edwards

  • Range of antinuclear antibodies in "healthy" individuals

    E. M. Tan;T. E. W. Feltkamp;J. S. Smolen;B. Butcher

  • Excessive production of interleukin 6/B cell stimulatory factor‐2 in rheumatoid arthritis

    T Hirano;T Matsuda;M Turner;N Miyasaka

  • Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis

    M J Elliott;R N Maini;M Feldmann;A Long-Fox

  • Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases.

    Marc Feldmann;Ravinder N Maini

  • Assessment of antibodies to double‐stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor α: Findings in open‐label and randomized placebo‐controlled trials

    P. J. Charles;R. J. T. Smeenk;J. De Jong;M. Feldmann

  • Localization of Tumor Necrosis Factor α in Synovial Tissues and at the Cartilage–Pannus Junction in Patients With Rheumatoid Arthritis

    C. Q. Chu;M. Field;M. Feldmann;R. N. Maini

  • Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis.

    Peter Charles;Michael J. Elliott;Diana Davis;Alison Potter

Frequent Co-Authors

Marc Feldmann
Marc Feldmann University of Oxford
Fionula M. Brennan
Fionula M. Brennan University of Oxford
Patrick J. Venables
Patrick J. Venables University of Oxford
Peter C. Taylor
Peter C. Taylor University of Oxford
Richard O. Williams
Richard O. Williams University of Oxford
Ewa M. Paleolog
Ewa M. Paleolog University of Oxford
Joachim R. Kalden
Joachim R. Kalden University of Erlangen-Nuremberg
Paul Emery
Paul Emery University of Leeds
Martin R. Turner
Martin R. Turner University of Oxford
Andrew P. Cope
Andrew P. Cope King's College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various advanced healthcare roles, many of which can be pursued through specialized online programs. For example, professionals interested in mental health can explore top psychiatric mental health nurse practitioner programs online, which offer flexible learning with strong clinical placement opportunities.

Affordability is a crucial factor when selecting an educational path. Many students seek affordable pmhnp programs that balance high-quality education with manageable tuition costs, making advanced degrees more accessible without compromising on credentials.

Career-wise, the Doctor of Nursing Practice (DNP) degree offers lucrative options. Understanding the dnp salary by specialty helps prospective students identify which fields provide the best financial rewards and align with their career goals in immunology and related disciplines.

For nurses aiming to expand their expertise, bridge programs such as fnp to acnp bridge program online provide a streamlined pathway to transition from family nurse practitioner roles to acute care specialties, enhancing scope of practice and patient impact.

Best Scientists Citing Ravinder N. Maini

Trending Scientists

Recently Published Articles